Neomycin Exhibits Immunomodulatory and Antiviral Activity Against Influenza B Virus
Viruses · 07.04.2026 · 18 (4) · 444
DOI: 10.3390/v18040444 ↗Kurz gefasst
Fachartikel in der Zeitschrift Viruses, online erschienen am 07.04.2026. Verfasst von Ekaterina Romanovskaya-Romanko und 7 weiteren Autor:innen. Beteiligte Einrichtung: Smorodintsev Research Institute of Influenza, Ministry of Health of the Russian Federation, Saint-Petersburg 197022, Russia. Hauptthemen laut MEDLINE: Neomycin, Antiviral Agents, Orthomyxoviridae Infections, Influenza B virus. Die Arbeit nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The Ministry of Health of the Russian Federation.
Abstract (Originalsprache)
Viral infections remain a global public health challenge. Stimulating the innate immune system is a potent therapeutic strategy that promotes pathogen clearance, directly impacting disease severity and clinical outcomes. Interferons and interferon-stimulated genes (ISGs) are critical components of this antiviral defense system. Neomycin, an aminoglycoside antibiotic, can induce ISG expression and help establish an antiviral state. In this study, we demonstrated that neomycin induces the production of pro-inflammatory cytokines (IL1β, TNFα, IL6, GM-CSF, and IFN-γ) in peripheral mononuclear blood cells (PBMCs) and activates key antiviral ISGs, including MxA, OAS1, and IRF7. The protein expression profiles elicited by neomycin were comparable to those induced by poly(I:C). Intranasal delivery of neomycin to CBA and BALB/c mice induced various ISGs in both the respiratory tract and splenic tissues. Prophylactic administration of neomycin significantly inhibited influenza B virus replication in the lung and nasal turbinates of CBA mice in a sublethal infection model. Overall, our data suggest that neomycin, when used prophylactically alone or combined with other antiviral strategies, shows considerable potential for the attenuation of influenza B virus infections.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Smorodintsev Research Institute of Influenza, Ministry of Health of the Russian Federation, Saint-Petersburg 197022, Russia.
ORCID-Profile: Ekaterina Romanovskaya-Romanko, Marina Plotnikova, Anna-Polina Shurygina, Marina Shuklina, Sergey Klotchenko
Förderung
- The Ministry of Health of the Russian Federation
Zitieren
APA
Romanovskaya-Romanko, E., Plotnikova, M., Shurygina, A. P., Shuklina, M., Klotchenko, S., Buzitskaya, Z., Lioznov, D., & Stukova, M. (2026). Neomycin Exhibits Immunomodulatory and Antiviral Activity Against Influenza B Virus. Viruses, 18(4), 444. https://doi.org/10.3390/v18040444
Vancouver
Romanovskaya-Romanko E, Plotnikova M, Shurygina AP, Shuklina M, Klotchenko S, Buzitskaya Z, et al. Neomycin Exhibits Immunomodulatory and Antiviral Activity Against Influenza B Virus. Viruses. 2026;18(4):444. doi:10.3390/v18040444
BibTeX
@article{RomanovskayaRomanko2026,
author = {Romanovskaya-Romanko, Ekaterina and Plotnikova, Marina and Shurygina, Anna-Polina and Shuklina, Marina and Klotchenko, Sergey and Buzitskaya, Zhanna and Lioznov, Dmitry and Stukova, Marina},
title = {Neomycin Exhibits Immunomodulatory and Antiviral Activity Against Influenza B Virus},
journal = {Viruses},
year = {2026},
volume = {18},
number = {4},
pages = {444},
doi = {10.3390/v18040444}
}
EUVIMED